Lazar T Mathew

Title: Innovations of Lazar T Mathew in Radiolabeled Peptide Analog Technology

Introduction

Lazar T Mathew is a notable inventor based in Delhi, India. He has made significant contributions to the field of medical imaging and therapy through his innovative work on radiolabeled peptide analogs. His research focuses on the development of agents that can selectively target specific receptors in mammalian systems, which has important implications for both diagnosis and treatment of diseases.

Latest Patents

Lazar T Mathew holds a patent for "Radiolabeled vasoactive intestinal peptide analogs for diagnosis and radiotherapy." This invention encompasses radiolabeled peptide analogs of vasoactive intestinal peptide (VIP) that are labeled with a radionuclide. These agents are useful for imaging target sites within living systems. The invention particularly provides radiolabeled VIP derivatives that bind selectively to the VIP receptor on target cells. The methods for radiolabeling these peptides with radionuclides and their use as scintigraphic imaging agents are also included in this patent. The radiolabeled VIP derivatives exhibit pharmacological activity, making them useful for visualizing VIP-receptor positive tumors and metastases, as well as for therapeutic purposes.

Career Highlights

Lazar T Mathew is associated with the Dabur Research Foundation, where he continues to advance his research in the field of peptide analogs. His work has garnered attention for its potential applications in medical diagnostics and treatment.

Collaborations

Some of his notable coworkers include Anand C Burman and Sudhanand Prasad, who have collaborated with him on various research projects.

Conclusion

Lazar T Mathew's innovative work in the field of radiolabeled peptide analogs represents a significant advancement in medical technology. His contributions have the potential to improve diagnostic and therapeutic strategies for treating diseases effectively.